Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients

Fatigue is a major burden for breast cancer patients undergoing adjuvant therapy. Yet, its pathophysiology is still not well understood. Hypothesized mechanisms include dysregulations in the hypothalamic-pituitary-adrenal (HPA) axis, which may be reflected in alterations in the diurnal cortisol patt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmidt, Martina (VerfasserIn) , Semik, Johanna (VerfasserIn) , Habermann, Nina (VerfasserIn) , Wiskemann, Joachim (VerfasserIn) , Ulrich, Cornelia (VerfasserIn) , Steindorf, Karen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Brain, behavior and immunity
Year: 2015, Jahrgang: 52, Pages: 98-105
ISSN:1090-2139
DOI:10.1016/j.bbi.2015.10.005
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bbi.2015.10.005
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0889159115300301
Volltext
Verfasserangaben:Martina E. Schmidt, Johanna Semik, Nina Habermann, Joachim Wiskemann, Cornelia M. Ulrich, Karen Steindorf
Beschreibung
Zusammenfassung:Fatigue is a major burden for breast cancer patients undergoing adjuvant therapy. Yet, its pathophysiology is still not well understood. Hypothesized mechanisms include dysregulations in the hypothalamic-pituitary-adrenal (HPA) axis, which may be reflected in alterations in the diurnal cortisol patterns. However, studies on the association between cortisol and fatigue during adjuvant cancer therapy are rare.
Beschreibung:Available online 9 October 2015
Gesehen am 19.05.2020
Beschreibung:Online Resource
ISSN:1090-2139
DOI:10.1016/j.bbi.2015.10.005